002223 鱼跃医疗
午间休市 09-18 11:30:00
资讯
新帖
简况
老将王景春回归 光大理财将迎第三任董事长！上半年净利润9.29亿
市场资讯 · 09-13
老将王景春回归 光大理财将迎第三任董事长！上半年净利润9.29亿
鱼跃医疗的多事之秋
锦缎 · 09-02
鱼跃医疗的多事之秋
鱼跃医疗：目前公司暂无猴痘检测相关业务
证券之星 · 08-31
鱼跃医疗：目前公司暂无猴痘检测相关业务
建仓鱼跃医疗、中国国贸与欧派家居，张坤：投资与奥运跳水比赛的计分方式并不相同
澎湃新闻 · 08-30
建仓鱼跃医疗、中国国贸与欧派家居，张坤：投资与奥运跳水比赛的计分方式并不相同
德邦证券：给予鱼跃医疗买入评级
证券之星 · 08-29
德邦证券：给予鱼跃医疗买入评级
疫情红利不再鱼跃医疗营收利润双降 应收账款、商誉减值风险显现 | 医药半年报
新浪证券 · 08-29
疫情红利不再鱼跃医疗营收利润双降 应收账款、商誉减值风险显现 | 医药半年报
群益证券：给予鱼跃医疗增持评级，目标价位38.0元
证券之星 · 08-28
群益证券：给予鱼跃医疗增持评级，目标价位38.0元
中国银河：给予鱼跃医疗买入评级
证券之星 · 08-27
中国银河：给予鱼跃医疗买入评级
华源证券：给予鱼跃医疗买入评级
证券之星 · 08-27
华源证券：给予鱼跃医疗买入评级
平安证券：给予鱼跃医疗买入评级
证券之星 · 08-27
平安证券：给予鱼跃医疗买入评级
鱼跃医疗中报营利双降，产品线“喜忧参半”，呼吸业务收入降幅最大
证券之星 · 08-26
鱼跃医疗中报营利双降，产品线“喜忧参半”，呼吸业务收入降幅最大
东吴证券：给予鱼跃医疗买入评级
证券之星 · 08-26
东吴证券：给予鱼跃医疗买入评级
鱼跃医疗：有知名机构淡水泉，彤源投资，进化论资产参与的多家机构于8月24日调研我司
证券之星 · 08-25
鱼跃医疗：有知名机构淡水泉，彤源投资，进化论资产参与的多家机构于8月24日调研我司
国金证券：给予鱼跃医疗买入评级
证券之星 · 08-25
国金证券：给予鱼跃医疗买入评级
鱼跃医疗(002223)7月10日股东户数4万户，较上期减少4.42%
证券之星 · 08-24
鱼跃医疗(002223)7月10日股东户数4万户，较上期减少4.42%
鱼跃医疗获得发明专利授权：“一种多参数监护仪控制方法和多参数监护仪”
证券之星 · 08-24
鱼跃医疗获得发明专利授权：“一种多参数监护仪控制方法和多参数监护仪”
鱼跃医疗新注册《鱼跃医疗持续葡萄糖数据监测应用程序Android手表版软件V1.0.0.0》等2个项目的软件著作权
证券之星 · 08-24
鱼跃医疗新注册《鱼跃医疗持续葡萄糖数据监测应用程序Android手表版软件V1.0.0.0》等2个项目的软件著作权
鱼跃医疗(002223.SZ)发布上半年业绩，净利润11.2亿元，下降25.02%
智通财经 · 08-23
鱼跃医疗(002223.SZ)发布上半年业绩，净利润11.2亿元，下降25.02%
鱼跃医疗最新公告：上半年净利润同比下降25.02% 拟10派4元
证券之星 · 08-23
鱼跃医疗最新公告：上半年净利润同比下降25.02% 拟10派4元
鱼跃医疗获得发明专利授权：“可进行反电动势回收的电机驱动电路和呼吸机”
证券之星 · 08-21
鱼跃医疗获得发明专利授权：“可进行反电动势回收的电机驱动电路和呼吸机”
加载更多
公司概况
公司名称：
江苏鱼跃医疗设备股份有限公司
所属行业：
专用设备制造业
上市日期：
2008-04-18
主营业务：
江苏鱼跃医疗设备股份有限公司的主营业务是研发、制造和销售医疗器械产品及提供相关解决方案。公司产品主要集中在呼吸制氧、糖尿病护理、感染控制解决方案、家用类电子检测及体外诊断、急救与临床及康复器械等业务领域。公司目前拥有“鱼跃yuwell”、“洁芙柔”、“华佗Hwato”、“金钟JZ”、“安尔碘”、“普美康PRIMEDIC”、“六六视觉”等几大主要品牌。“鱼跃”品牌深入人心，依托鱼跃产品力的不断提升及有效的品牌传播，以及旗下产品在海内外医疗一线的卓越表现，公司品牌价值和品牌优势显著提升。
发行价格：
9.48
{"stockData":{"symbol":"002223","market":"SZ","secType":"STK","nameCN":"鱼跃医疗","latestPrice":31.38,"timestamp":1726631481000,"preClose":30.78,"halted":0,"volume":4406050,"delay":0,"floatShares":939000000,"shares":1002000000,"eps":2.0171,"marketStatus":"午间休市","marketStatusCode":3,"change":0.6,"latestTime":"09-18 11:30:00","open":30.77,"high":31.65,"low":30.68,"amount":138000000,"amplitude":0.0315,"askPrice":31.38,"askSize":6,"bidPrice":31.35,"bidSize":23,"shortable":0,"etf":0,"ttmEps":2.0171,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726635600000},"adr":0,"adjPreClose":30.78,"symbolType":"stock","openAndCloseTimeList":[[1726623000000,1726630200000],[1726635600000,1726642800000]],"highLimit":33.86,"lowLimit":27.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1002476929,"pbRate":2.55,"roa":"--","roe":"9.17%","epsLYR":2.41,"committee":-0.635556,"marketValue":31458000000,"floatMarketCap":29456000000,"peRate":15.556987,"changeRate":0.0195,"turnoverRate":0.0047,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-09-19。"},"requestUrl":"/m/hq/s/002223","defaultTab":"news","newsList":[{"id":"2467221477","title":"老将王景春回归 光大理财将迎第三任董事长！上半年净利润9.29亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2467221477","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467221477?lang=zh_cn&edition=full","pubTime":"2024-09-13 20:21","pubTimestamp":1726230060,"startTime":"0","endTime":"0","summary":" 光大理财将迎来新任董事长。 近日多家媒体报道，光大银行呼和浩特分行行长王景春已调任光大理财任党委书记，待履行必要的程序后有望出任光大理财董事长。 王景春是光大银行“老将”，先后担任光大理财副总经理、光大银行呼和浩特分行行长，如今回归光大理财，有望成为光大理财成立以来的第三任董事长。光大理财首任董事长是张旭阳，其目前的职务是光大银行董事会秘书、首席业务总监。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/lczx/2024-09-13/doc-incnzmih5524139.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/lczx/2024-09-13/doc-incnzmih5524139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1146622755.USD","LU1064130708.USD","BK0168","LU2153591404.USD","LU2357125470.USD","002223","BK0188","EVS.SI","300750","LU0502904849.HKD","LU1831875114.USD","LU0823414551.USD","LU1188198961.HKD","LU0823426308.USD","LU2249611893.SGD","LU0509642566.USD","LU0405327148.USD","002850","LU2294711713.HKD","LU1580142542.USD","LU0228659784.USD","LU0463099449.HKD","LU1997245177.USD","LU0348805143.USD","BK0256","LU0405327494.USD","LU1655091616.SGD","LU1794554557.SGD","BK0235","LU0572944931.SGD","LU0231483743.USD","LU1979443071.USD","LU2238339852.HKD","LU2348773727.SGD","LU0455707207.USD","LU0823426480.USD","LU0359201612.USD","BK0197","600161","001301","LU0823414478.USD","LU0828237510.HKD","BK0239","LU1997244956.HKD","LU1997245094.SGD","BK0185","LU0259732245.USD","LU1023057109.AUD","BK0114","LU0269904917.USD"],"gpt_icon":0},{"id":"2464962023","title":"鱼跃医疗的多事之秋","url":"https://stock-news.laohu8.com/highlight/detail?id=2464962023","media":"锦缎","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464962023?lang=zh_cn&edition=full","pubTime":"2024-09-02 08:04","pubTimestamp":1725235443,"startTime":"0","endTime":"0","summary":"就当市场认为鱼跃医疗将会在今年趁势完成百亿营收的目标时，鱼跃医疗业绩却发生了反转。8月23日，鱼跃医疗发布2024年中报，营收与净利润双双下降。规模和投资收益的不断扩增，带动鱼跃医疗业绩呈现出持续增长态势。此后，鱼跃医疗股价持续处于300亿左右水平市值，成为业内的头部玩家之一。今年5月份以来，云南白药爆发“窝案”，尽管鱼跃医疗一再撇清关系，但其股价还是不可避免地受到波及。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8cXfIdtdh3F","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK0188","BK0251","BK0070","BK0185","BK0197","BK0114","BK0146","002223"],"gpt_icon":0},{"id":"2463354723","title":"鱼跃医疗：目前公司暂无猴痘检测相关业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2463354723","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463354723?lang=zh_cn&edition=full","pubTime":"2024-08-31 13:02","pubTimestamp":1725080526,"startTime":"0","endTime":"0","summary":"证券之星消息，鱼跃医疗(002223)08月31日在投资者关系平台上答复投资者关心的问题。投资者：贵公司有没有猴豆病毒相关的业务？鱼跃医疗董秘：您好，目前公司暂无猴痘检测相关业务，感谢您的关注。投资者：董秘，您好！请问公司截至8月20日的股东人数是多少？谢谢鱼跃医疗董秘：您好，截至2024年8月20日公司股东总户数为40000多户，谢谢。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100012520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002223","BK0188","BK0185","BK0146","BK0197","BK0114","BK0070"],"gpt_icon":0},{"id":"2463210031","title":"建仓鱼跃医疗、中国国贸与欧派家居，张坤：投资与奥运跳水比赛的计分方式并不相同","url":"https://stock-news.laohu8.com/highlight/detail?id=2463210031","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463210031?lang=zh_cn&edition=full","pubTime":"2024-08-30 07:18","pubTimestamp":1724973480,"startTime":"0","endTime":"0","summary":"8月30日零点，易方达基金副总经理张坤旗下在管基金纷纷披露2024年中期报告。张坤表示，一些企业面临的困境，正如想要观看一场盛大的沿街演出，就不得不踮起脚尖，而很快，其他人也都逐渐踮起了脚尖，尽管累得几乎抽筋，却还是很难看到想看的演出。张坤认为，人们往往倾向于崇尚复杂的东西，不屑于显而易见的东西，认为它们太过简单。事实上，投资与奥运跳水比赛的计分方式并不相同，难度系数并不重要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408300720149f66e007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408300720149f66e007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","BK0188","BK0114","BK0185","BK0251","BK0260","BK0273","002223","BK0070","603833","BK0196","BK0197","600007"],"gpt_icon":0},{"id":"2463768004","title":"德邦证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2463768004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463768004?lang=zh_cn&edition=full","pubTime":"2024-08-29 12:03","pubTimestamp":1724904209,"startTime":"0","endTime":"0","summary":"德邦证券股份有限公司周新明近期对鱼跃医疗进行研究并发布了研究报告《鱼跃医疗24中报点评：高基数下业绩承压，海外提速》，本报告对鱼跃医疗给出买入评级，当前股价为32.56元。最新盈利预测明细如下：该股最近90天内共有14家机构给出评级，买入评级12家，增持评级2家；过去90天内机构目标均价为43.69。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900019175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002223"],"gpt_icon":0},{"id":"2463542805","title":"疫情红利不再鱼跃医疗营收利润双降 应收账款、商誉减值风险显现 | 医药半年报","url":"https://stock-news.laohu8.com/highlight/detail?id=2463542805","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463542805?lang=zh_cn&edition=full","pubTime":"2024-08-29 09:06","pubTimestamp":1724893560,"startTime":"0","endTime":"0","summary":" 近日，鱼跃医疗披露2024年半年度报告。公告显示，公司上半年实现营业收入约为43.08亿元，同比下降13.50%；归母净利润约为11.2亿元，同比下降25.02%；扣非净利润为9.64亿元，同比下降23.19%；经营活动产生的现金流量净额为10.13亿元，同比下降32.42%。 结合往期半年度业绩表现来看，2024年上半年公司营收、归母净利润均出现五年以来的最大同比降幅，扣非净利润尚不及2020年同期。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/observe/2024-08-29/doc-incmhmen4391517.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2024-08-29/doc-incmhmen4391517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","09939","002223"],"gpt_icon":0},{"id":"2462483153","title":"群益证券：给予鱼跃医疗增持评级，目标价位38.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462483153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462483153?lang=zh_cn&edition=full","pubTime":"2024-08-28 14:36","pubTimestamp":1724826970,"startTime":"0","endTime":"0","summary":"群益证券(香港)有限公司王睿哲近期对鱼跃医疗进行研究并发布了研究报告《高基期影响增速，糖尿病护理板块高速增长》，本报告对鱼跃医疗给出增持评级，认为其目标价位为38.00元，当前股价为32.72元，预期上涨幅度为16.14%。其中Q2单季度实现营收20.8亿元，YOY-8.8%，录得归母净利润4.6亿元，YOY-41%，扣非后归母净利润4.1亿元，YOY-25.1%。Q2期间费用率为26.3%，同比增4个百分点，主要疫情后销售回归正常，家用品类销售推广支出增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800022027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002223"],"gpt_icon":0},{"id":"2462718248","title":"中国银河：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462718248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462718248?lang=zh_cn&edition=full","pubTime":"2024-08-27 13:45","pubTimestamp":1724737519,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对鱼跃医疗进行研究并发布了研究报告《2024年中报业绩点评：需求波动影响表观业绩，业务向常态化回归》，本报告对鱼跃医疗给出买入评级，当前股价为32.1元。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级10家，增持评级1家；过去90天内机构目标均价为43.69。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700018185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601881","002223"],"gpt_icon":0},{"id":"2462185951","title":"华源证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462185951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462185951?lang=zh_cn&edition=full","pubTime":"2024-08-27 12:15","pubTimestamp":1724732105,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对鱼跃医疗进行研究并发布了研究报告《血糖等常规品种表现较好，海外显著提速》，本报告对鱼跃医疗给出买入评级，当前股价为32.35元。2020年后通过创新重塑，聚焦三大高成长赛道，增长潜力大，维持公司“买入”评级。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级10家，增持评级1家；过去90天内机构目标均价为43.69。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700017095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223","161027"],"gpt_icon":0},{"id":"2462916185","title":"平安证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462916185","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462916185?lang=zh_cn&edition=full","pubTime":"2024-08-27 12:14","pubTimestamp":1724732096,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道,裴晓鹏近期对鱼跃医疗进行研究并发布了研究报告《国内承压下增长具备韧性，海外市场不断打开成长空间》，本报告对鱼跃医疗给出买入评级，当前股价为32.35元。 维持“强烈推荐”评级。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级10家，增持评级1家；过去90天内机构目标均价为43.69。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700017090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223","161027"],"gpt_icon":0},{"id":"2462963132","title":"鱼跃医疗中报营利双降，产品线“喜忧参半”，呼吸业务收入降幅最大","url":"https://stock-news.laohu8.com/highlight/detail?id=2462963132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462963132?lang=zh_cn&edition=full","pubTime":"2024-08-26 16:41","pubTimestamp":1724661673,"startTime":"0","endTime":"0","summary":"日前，鱼跃医疗发布的2024年半年报显示，今年上半年营业收入、归属净利润双双下滑。财报显示，鱼跃医疗今年上半年实现营业总收入43.08亿元，同比下降13.5%，实现营业利润12.88亿元，同比下降28.34%，归属净利润11.2亿元，同比下降25.02%，扣非后净利润9.64亿元，同比下降23.19%。从鱼跃医疗各业务条线表现看，其与公众应急需求相关的呼吸制氧、感染控制、家用电子检测及体外诊断三大业务，在今年上半年收入下滑均为双位数。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024082600020893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0185","BK0070","BK0251","002223","BK0188","BK0114","BK0146"],"gpt_icon":0},{"id":"2462993202","title":"东吴证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462993202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462993202?lang=zh_cn&edition=full","pubTime":"2024-08-26 13:15","pubTimestamp":1724649321,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对鱼跃医疗进行研究并发布了研究报告《2024年半年报业绩点评：上半年受疫情基数扰动，收入符合预期》，本报告对鱼跃医疗给出买入评级，当前股价为32.68元。考虑到公司明后年有新品上市，海外市场不断拓展，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为43.81。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600012210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","002223"],"gpt_icon":0},{"id":"2462621649","title":"鱼跃医疗：有知名机构淡水泉，彤源投资，进化论资产参与的多家机构于8月24日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2462621649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462621649?lang=zh_cn&edition=full","pubTime":"2024-08-25 19:12","pubTimestamp":1724584332,"startTime":"0","endTime":"0","summary":"具体内容如下：问：公司血糖板块产品，在国内外实现了较好的发展，并能够持续升市场份额，请公司在包括营销渠道等方面有哪些市场策略？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082500003552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0146","BK0114","BK0251","002223","BK0188","BK0197","BK0185"],"gpt_icon":0},{"id":"2462194617","title":"国金证券：给予鱼跃医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462194617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462194617?lang=zh_cn&edition=full","pubTime":"2024-08-25 12:30","pubTimestamp":1724560233,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司袁维,何冠洲近期对鱼跃医疗进行研究并发布了研究报告《呼吸制氧回归常态发展，血糖及急救板块增长亮眼》，本报告对鱼跃医疗给出买入评级，当前股价为34.09元。 半年度进一步现金分红，持续回报投资者。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为43.81。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082500001280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223"],"gpt_icon":0},{"id":"2461717682","title":"鱼跃医疗(002223)7月10日股东户数4万户，较上期减少4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461717682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461717682?lang=zh_cn&edition=full","pubTime":"2024-08-24 17:03","pubTimestamp":1724490204,"startTime":"0","endTime":"0","summary":"证券之星消息，近日鱼跃医疗披露，截至2024年7月10日公司股东户数为4.0万户，较6月30日减少1848.0户，减幅为4.42%。在医疗器械行业个股中，鱼跃医疗股东户数高于行业平均水平，截至7月10日，医疗器械行业平均股东户数为2.04万户。从股价来看，2024年6月30日至2024年7月10日，鱼跃医疗区间跌幅为3.11%，在此期间股东户数减少1848.0户，减幅为4.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082400009627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0146","BK0114","BK0188","002223","BK0070","BK0197","BK0251"],"gpt_icon":0},{"id":"2461654136","title":"鱼跃医疗获得发明专利授权：“一种多参数监护仪控制方法和多参数监护仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2461654136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461654136?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:36","pubTimestamp":1724438197,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示鱼跃医疗新获得一项发明专利授权，专利名为“一种多参数监护仪控制方法和多参数监护仪”，专利申请号为CN202210164614.8，授权日为2024年8月23日。今年以来鱼跃医疗新获得专利授权60个，较去年同期增加了22.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082400003548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223","BK0114","BK0146","BK0197","BK0070","BK0251","BK0185","BK0188"],"gpt_icon":0},{"id":"2461333545","title":"鱼跃医疗新注册《鱼跃医疗持续葡萄糖数据监测应用程序Android手表版软件V1.0.0.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2461333545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461333545?lang=zh_cn&edition=full","pubTime":"2024-08-24 01:36","pubTimestamp":1724434597,"startTime":"0","endTime":"0","summary":"证券之星消息，近日鱼跃医疗（002223）新注册了2个项目的软件著作权，包括《鱼跃医疗持续葡萄糖数据监测应用程序Android手表版软件V1.0.0.0》、《鱼跃医疗持续葡萄糖数据监测应用程序watchOS版软件V1.0.0.0》等。今年以来鱼跃医疗新注册软件著作权2个，较去年同期减少了50%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.7亿元，同比减1.48%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082400002039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0185","BK0070","BK0251","002223","BK0188","BK0114","BK0146"],"gpt_icon":0},{"id":"2461979596","title":"鱼跃医疗(002223.SZ)发布上半年业绩，净利润11.2亿元，下降25.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461979596","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461979596?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:51","pubTimestamp":1724417506,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鱼跃医疗 发布2024年半年度报告，报告期内，公司实现营业收入43.08亿元，同比下降13.50%。实现归属于上市公司股东的净利润11.2亿元，同比下降25.02%。截至报告期末，公司资产总额为156.17亿元，资产负债率21.51%，货币资金65.67亿元。报告期内，与上年同期高基数相比较，公司呼吸治疗解决方案板块业务规模有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002223"],"gpt_icon":0},{"id":"2461564507","title":"鱼跃医疗最新公告：上半年净利润同比下降25.02% 拟10派4元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461564507","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461564507?lang=zh_cn&edition=full","pubTime":"2024-08-23 19:10","pubTimestamp":1724411410,"startTime":"0","endTime":"0","summary":"鱼跃医疗披露半年度报告，公司2024年半年度实现营业收入为43.08亿元，同比下降13.5%；归母净利润11.2亿元，同比下降25.02%；基本每股收益1.12元。公司拟每10股派发现金红利4元（含税）。报告期内，公司业务已逐步回归常态化的可持续发展轨道，由于上年同期社会公共需求波动，基数较高。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300040192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002223"],"gpt_icon":0},{"id":"2461983840","title":"鱼跃医疗获得发明专利授权：“可进行反电动势回收的电机驱动电路和呼吸机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2461983840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461983840?lang=zh_cn&edition=full","pubTime":"2024-08-21 02:31","pubTimestamp":1724178661,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示鱼跃医疗新获得一项发明专利授权，专利名为“可进行反电动势回收的电机驱动电路和呼吸机”，专利申请号为CN202111659389.7，授权日为2024年8月20日。解决了现有技术中存在的反电动势回收电路仅能对反电动势进行回收，不能将回收的反电动势重新利用的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100003480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","BK0188","002223","BK0146","BK0070","BK0197","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2008-04-18","address":"江苏省镇江市丹阳市开发区百胜路1号","stockEarnings":[{"period":"1week","weight":-0.0182},{"period":"1month","weight":-0.1226},{"period":"3month","weight":-0.2227},{"period":"6month","weight":-0.0977},{"period":"1year","weight":-0.0753},{"period":"ytd","weight":-0.0916}],"companyName":"江苏鱼跃医疗设备股份有限公司","boardCode":"AI0035","perCapita":"0股","boardName":"专用设备制造业","registeredCapital":"100247万元","compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.1083},{"period":"6month","weight":-0.1148},{"period":"1year","weight":-0.1351},{"period":"ytd","weight":-0.091}],"survey":" 江苏鱼跃医疗设备股份有限公司的主营业务是研发、制造和销售医疗器械产品及提供相关解决方案。公司产品主要集中在呼吸制氧、糖尿病护理、感染控制解决方案、家用类电子检测及体外诊断、急救与临床及康复器械等业务领域。公司目前拥有“鱼跃yuwell”、“洁芙柔”、“华佗Hwato”、“金钟JZ”、“安尔碘”、“普美康PRIMEDIC”、“六六视觉”等几大主要品牌。“鱼跃”品牌深入人心，依托鱼跃产品力的不断提升及有效的品牌传播，以及旗下产品在海内外医疗一线的卓越表现，公司品牌价值和品牌优势显著提升。","serverTime":1726631537818,"listedPrice":9.48,"stockholders":"54人(较上一季度减少99.87%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鱼跃医疗(002223)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鱼跃医疗(002223)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鱼跃医疗,002223,鱼跃医疗股票,鱼跃医疗股票老虎,鱼跃医疗股票老虎国际,鱼跃医疗行情,鱼跃医疗股票行情,鱼跃医疗股价,鱼跃医疗股市,鱼跃医疗股票价格,鱼跃医疗股票交易,鱼跃医疗股票购买,鱼跃医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鱼跃医疗(002223)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鱼跃医疗(002223)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}